KRTAP10-2

Chr 21

keratin associated protein 10-2

Also known as: KAP10.2, KAP18-2, KAP18.2, KRTAP10.2, KRTAP18-2, KRTAP18.2

The protein is a high-sulfur keratin-associated protein that forms a matrix with keratin intermediate filaments through extensive disulfide cross-linking, providing structural integrity to hair shafts. Mutations in this gene have not been definitively associated with any recognized disease phenotypes in current medical literature. The gene shows tolerance to loss-of-function variants, consistent with its specific role in hair fiber structure rather than essential cellular processes.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
0
Pubs (1 yr)
93
P/LP submissions
0%
P/LP missense
1.81
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryKRTAP10-2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.00) despite low pLI — interpret in context.
📋
ClinVar Variants
88 unique Pathogenic / Likely Pathogenic· 54 VUS of 150 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.81LOEUF
pLI 0.351
Z-score 0.74
OE 0.00 (0.001.81)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-1.08Z-score
OE missense 1.26 (1.111.43)
172 obs / 136.4 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.00 (0.001.81)
00.351.4
Missense OE1.26 (1.111.43)
00.61.4
Synonymous OE1.46
01.21.6
LoF obs/exp: 0 / 0.6Missense obs/exp: 172 / 136.4Syn Z: -2.76
DN
0.89top 5%
GOF
0.80top 10%
LOF
0.3941th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

150 submitted variants in ClinVar

Classification Summary

Pathogenic84
Likely Pathogenic4
VUS54
Likely Benign7
Conflicting1
84
Pathogenic
4
Likely Pathogenic
54
VUS
7
Likely Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
84
0
84
Likely Pathogenic
0
0
4
0
4
VUS
0
35
19
0
54
Likely Benign
0
6
0
1
7
Benign
0
0
0
0
0
Conflicting
1
Total0411071150

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

KRTAP10-2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found